Biomax Biomax, Pierre Fabre Collaborate on Antibody Database The partners will continue to develop an integrated sequence and knowledge database to support Pierre Fabre's therapeutic antibody development efforts. Biomax Informatics Expands US Operations NEW YORK (GenomeWeb) – Biomax Informatics AG has moved the headquarters of Biomax Informatics Inc., its wholly owned subsidiary in the United States, from Cambridge, Mass. to New Glarus, Wis. Biomax to Invest €1 million in Mental Health Informatics Premium Biomax Informatics said this week that it will invest nearly €1 million over the next four years to enable its bioinformatics infrastructure support mental health applications. METSY Consortium to Develop Neuroimaging, Bioinformatics Tools for Psychosis Biomarker Studies Premium This article has been updated to include comments from Biomax Informatics about its participation in the consortium. Biomax Develops Management Infrastructure for Respiratory Disease Consortium Premium Biomax Informatics said this week that its knowledge management infrastructure is being used to manage information for a European-funded project focused on studying airway diseases. Jun 22, 2012 Biomax Informatics Puts BioXM Platform Through Paces with European COPD Project Premium Jul 19, 2011 Biomax Expands Agreement with Royal DSM to Include Synthetic Biology Solutions Jun 17, 2011 Biomax Expands Viscovery Data-Mining Software into Life Science Market Premium Breaking News Genetic Contributors to Plasma Protein Levels Unearthed in Multiple Studies Standard BioTools, SomaLogic to Merge Arima Genomics, Protean BioDiagnostics Launch 3D Genomics Cancer Testing Joint Venture Pathnostics UTI Test Nabs New York State Approval NanoString, A*Star, Next Level Genomics to Launch Spatial Biology Laboratory in Singapore The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.